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Fasting has been practiced for millennia, but, only recently, studies have shed light on its role in adaptive
cellular responses that reduce oxidative damage and inflammation, optimize energymetabolism, and bolster
cellular protection. In lower eukaryotes, chronic fasting extends longevity, in part, by reprogramming meta-
bolic and stress resistance pathways. In rodents intermittent or periodic fasting protects against diabetes,
cancers, heart disease, and neurodegeneration, while in humans it helps reduce obesity, hypertension,
asthma, and rheumatoid arthritis. Thus, fasting has the potential to delay aging and help prevent and treat
diseases while minimizing the side effects caused by chronic dietary interventions.Introduction
In humans, fasting is achieved by ingesting no or minimal
amounts of food and caloric beverages for periods that typi-
cally range from 12 hr to 3 weeks. Many religious groups
incorporate periods of fasting into their rituals including
Muslims, who fast from dawn until dusk during the month of
Ramadan, and Christians, Jews, Buddhists, and Hindus, who
traditionally fast on designated days of the week or calendar
year. In many clinics, patients are now monitored by
physicians while undergoing water only or very low calorie
(less than 200 kcal/day) fasting periods lasting from 1 week
or longer for weight management and for disease prevention
and treatment. Fasting is distinct from caloric restriction
(CR), in which the daily caloric intake is reduced chronically
by 20%–40%, but meal frequency is maintained. Starvation
is instead a chronic nutritional insufficiency that is commonly
used as a substitute for the word fasting, particularly in lower
eukaryotes, but is also used to define extreme forms of
fasting, which can result in degeneration and death. We now
know that fasting results in ketogenesis; promotes potent
changes in metabolic pathways and cellular processes such
as stress resistance, lipolysis, and autophagy; and can have
medical applications that, in some cases, are as effective as
those of approved drugs such as the dampening of seizures
and seizure-associated brain damage and the amelioration of
rheumatoid arthritis (Bruce-Keller et al., 1999; Hartman et al.,
2012; Mu¨ller et al., 2001). Findings from well-controlled inves-
tigations in experimental animals, and emerging human
studies, indicate that fasting may provide effective strategies
to reduce weight, delay aging, and optimize health. Here we
review the fascinating and potent effects of different forms of
fasting, including intermittent fasting (IF, including alternate
day fasting or 2 days a week fasting, for example) and periodic
fasting (PF) lasting three days or longer every 2 or more
weeks. We focus on fasting and minimize the discussion of
CR, a topic reviewed elsewhere (Fontana et al., 2010; Masoro,
2005).Lessons from Simple Organisms
The remarkable effects of the typical 20%–40%CR on aging and
diseases in mice and rats are often viewed as responses evolved
in mammals to adapt to periods of limited availability of food
(Fontana and Klein, 2007; Fontana et al., 2010; Masoro, 2005;
Weindruch andWalford, 1988). However, the cellular andmolec-
ular mechanisms responsible for the protective effects of CR
have likely evolved billions of years earlier in prokaryotes at-
tempting to survive in an environment largely or completely
devoid of energy sources while avoiding age-dependent dam-
age that could compromise fitness. In fact, E. coli switched
from a nutrient-rich broth to a calorie-free medium survive four
times longer, an effect reversed by the addition of various nutri-
ents—but not acetate, a carbon source associated with starva-
tion conditions (Figure 1A) (Gonidakis et al., 2010). The effect
of rich medium, but not acetate, in reducing longevity raises
the possibility that a ketone-body-like carbon source such as
acetate may be part of an ‘‘alternate metabolic program’’ that
evolved billions of years ago in microorganisms and that now
allows mammals to survive during periods of food deprivation
by obtaining much of the energy by catabolizing fatty acids
and ketone bodies, including acetoacetate and b-hydroxybuty-
rate (Cahill, 2006).
In the yeast S. cerevisiae, switching cells from standard
growth medium to water also causes a consistent 2-fold chrono-
logical lifespan extension as well, as a major increase in the
resistance to multiple stresses (Figure 1B) (Longo et al., 1997,
2012). The mechanisms of food-deprivation-dependent lifespan
extension involve the downregulation of the amino acid response
Tor-S6K (Sch9) pathway, as well as of the glucose-responsive
Ras-adenylate cyclase-PKA pathway, resulting in the activation
of the serine/threonine kinase Rim15, a key enzyme coordinating
the protective responses (Fontana et al., 2010). The inactivation
of Tor-S6K and Ras-AC-PKA and activation of Rim15 results in
increased transcription of genes, including superoxide dismu-
tases and heat shock proteins controlled by stress-responsive
transcription factors Msn2, Msn4, and Gis1, required for theCell Metabolism 19, February 4, 2014 ª2014 Elsevier Inc. 181
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Figure 1. Fasting Extends Lifespans of
Bacteria, Yeast, Worms, and Mice
(A) Lifespan of E. coli incubated in either LB medium
or nutrient-free NaCl (Gonidakis et al., 2010).
(B) Lifespan of S. cerevisiae incubated in either
nutrient-rich medium or water (Wei et al., 2008).
(C) Lifespan of C. elegans in standard nutrient-rich
medium or in medium with a 90% reduction or
complete removal of bacterial food (Kaeberlein
et al., 2006).
(D) Lifespan of mal C57BL/6J mice on alternating
day fasting initiated at 1–2 month of age (Goodrick
et al., 1990).
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(Wei et al., 2008). Notably, when switched to food deprivation
conditions, both bacteria and yeast enter a hypometabolic
mode that allows them to minimize the use of reserve carbon
sources and can also accumulate high levels of the ketone-
body-like acetic acid, analogously to mammals.
Another major model organism in which fasting extends life-
span is the nematode C. elegans. Food deprivation conditions
achieved by feeding worms little or no bacteria lead to a major
increase in lifespan (Figure 1C) (Kaeberlein et al., 2006; Lee
et al., 2006), which requires AMPK as well as the stress resis-
tance transcription factor DAF-16, similar to the role of transcrip-
tion factors Msn2/4 and Gis1 in yeast and FOXOs in flies and
mammals (Greer et al., 2007). Intermittent food deprivation
also extends lifespan in C. elegans by a mechanism involving
the small GTPase RHEB-1 (Honjoh et al., 2009).
In flies, most studies indicate that intermittent food deprivation
does not affect lifespan (Grandison et al., 2009). However, food
reduction or food dilution have been consistently shown to
extend Drosophila longevity (Piper and Partridge, 2007), sug-
gesting that flies can benefit from dietary restriction but may
be sensitive to even short starvation periods.
Together, these results indicate not only that food deprivation
can result in prolongevity effects in a wide variety of organisms
but also underline that different organisms have different
responses to fasting.
Adaptive Responses to Fasting in Mammals
In most mammals, the liver serves as the main reservoir of
glucose, which is stored in the form of glycogen. In humans, de-
pending upon their level of physical activity, 12 to 24 hr of fasting
typically results in a 20% or greater decrease in serum glucose
and depletion of the hepatic glycogen, accompanied by a switch182 Cell Metabolism 19, February 4, 2014 ª2014 Elsevier Inc.to a metabolic mode in which nonhepatic
glucose, fat-derived ketone bodies, and
free fatty acids are used as energy sources
(Figures 2 and 3). Whereas most tissues
can utilize fatty acids for energy, during
prolonged periods of fasting, the brain
relies on the ketone bodies b-hydroxy-
butyrate and acetoacetate, in addition
to glucose, for energy consumption
(Figure 3B). Ketone bodies are produced
in hepatocytes from the acetyl-CoA
generated from b-oxidation of fatty acids
released into the bloodstream by adipo-cytes, and also by the conversion of ketogenic amino acids. After
hepatic glycogen depletion, ketone bodies, fat-derived glycerol,
and amino acids account for the gluconeogenesis-dependent
generation of approximately 80 g/day of glucose, which ismostly
utilized by the brain. Depending on body weight and composi-
tion, the ketone bodies, free fatty acids, and gluconeogenesis
allow the majority of human beings to survive 30 or more days
in the absence of any food and allow certain species, such as
king penguins, to survive for over 5 months without food (Eich-
horn et al., 2011) (Figure 3C). In humans, during prolonged fast-
ing, the plasma levels of 3-b-hydroxybutyrate are about five
times those of free fatty acids and acetoacetic acid (Figure 3A
and 3B). The brain and other organs utilize ketone bodies in a
process termed ketolysis, in which acetoacetic acid and 3-b-hy-
droxybutyrate are converted into acetoacetyl-CoA and then
acetyl-CoA. These metabolic adaptations to fasting in mammals
are reminiscent of those described earlier for E. coli and yeast, in
which acetic acid accumulates in response to food deprivation
(Gonidakis et al., 2010; Longo et al., 2012). In yeast, glucose,
acetic acid, and ethanol, but not glycerol, which in fasting mam-
mals is generated from the breakdown of fats, accelerate aging
(Fabrizio et al., 2005;Wei et al., 2009). Thus, glycerol functions as
a carbon source that does not activate the proaging nutrient
signaling pathways but can be catabolized by cells. It will be
important to understand how the different carbon sources
generated during fasting affect cellular protection and aging,
and to determine whether glycerol, specific ketone bodies, or
fatty acids can provide nourishment while reducing cellular aging
in mammals, a possibility suggested by beneficial effects of a
dietary ketone precursor in a mouse model of Alzheimer’s dis-
ease (Kashiwaya et al., 2013). It will also be important to study,
in variousmodel organisms and humans, how high intake of spe-
cific types of fats (medium- versus long-chain fatty acids, etc.) in
brainstem
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Figure 2. Pivotal Roles of the Nervous and Endocrine Systems as Mediators of Adaptive Responses of Major Organ Systems to Intermittent
Fasting
IF modifies brain neurochemistry and neuronal network activity in ways that optimize brain function and peripheral energy metabolism. Four brain regions that are
particularly important in adaptive responses to IF include the hippocampus (cognitive processing), striatum (control of body movements), hypothalamus (Hyp,
control of food intake and body temperature), and brainstem (control of cardiovascular and digestive systems). The brain communicates with all of the peripheral
organs involved in energy metabolism. IF enhances parasympathetic activity (mediated by the neurotransmitter acetylcholine) in the autonomic neurons that
innervate the gut, heart, and arteries, resulting in improved gut motility and reduced heart rate and blood pressure. By depleting glycogen from liver cells, fasting
results in lipolysis and the generation of ketone bodies, causing a reduction in body fat. IF enhances insulin sensitivity of muscle and liver cells and reduces IGF-1
production. Levels of oxidative stress and inflammation are reduced throughout the body and brain in response to IF.
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genesis and glucose levels as well as aging and diseases.
Fasting and the Brain
In mammals, severe CR/food deprivation results in a decrease
in the size of most organs except the brain, and the testicles
in male mice (Weindruch and Sohal, 1997). From an evolutionary
perspective, this implies that maintenance of a high level of
cognitive function under conditions of food scarcity is of preem-
inent importance. Indeed, a highly conserved behavioral trait of
all mammals is to be active when hungry and sedentary when
satiated. In rodents, alternating days of normal feeding and fast-
ing (IF) can enhance brain function, as indicated by improve-
ments in performance on behavioral tests of sensory and motor
function (Singh et al., 2012) and learning and memory (Fonta´n-Lozano et al., 2007). The behavioral responses to IF are associ-
ated with increased synaptic plasticity and increased production
of new neurons from neural stem cells (Lee et al., 2002).
Particularly interesting with regard to adaptive responses of
the brain to limited food availability during human evolution is
brain-derived neurotrophic factor (BDNF). The genes encoding
BDNF and its receptor, TrkB, appeared in genomes relatively
recently, as they are present in vertebrates, but absent from
worms, flies, and lower species (Chao, 2000). The prominent
roles of BDNF in the regulation of energy intake and expenditure
in mammals is highlighted by the fact that the receptors for both
BDNF and insulin are coupled to the highly conserved PI3-ki-
nase-Akt and MAP kinase signaling pathways (Figure 4). Studies
of rats and mice have shown that running wheel exercise and
IF increase BDNF expression in several regions of the brain,Cell Metabolism 19, February 4, 2014 ª2014 Elsevier Inc. 183
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Figure 3. Fasting in Mammals
(A) Concentrations of ketone bodies (acetone,
b-hydroxybutyric acid, and acetoacetic acid) and
plasma free fatty acids (FFA) during 40 days of
fasting in humans. Note the more than three orders
of magnitude change in b-hydroxybutyrate and the
doubling of FFA.
(B) Brain substrate utilization in three fasting obese
volunteers after several weeks of food deprivation.
Many studies suggest that human brain cells can
survivewith little to no glucose, but this has not been
clearly demonstrated (redrawn from Cahill [2006]).
(C) Emperor penguins can fast for periods lasting for
over 5 months. The picture shows Emperor pen-
guins and their chicks a few weeks before fledging
(courtesy of Yvone le Maho). The parents go back
and forth between the open sea and their colony on
sea ice, next to a glacier, which offers protection
against wind, to regurgitate food conserved in their
stomach to feed their chicks while they are them-
selves fasting. Fasting penguins undergo three
phases (Le Maho et al., 1976; Le Maho et al., 1981;
Robin et al., 1987). The first phase (phase I) repre-
sents a transition between the fed state and star-
vation, during which the penguin stops utilizing diet-
derived energy. This phase, which lasts between
several hours and several days, is characterizedby a
rapid decrease in protein loss. The following phase
(phase II), is a ketotic phase associated with protein
sparing, which can last for several days in rats to
severalmonths in obesegeese, kingpenguin chicks,
bears, and seals (Adams and Costa, 1993; Atkinson
and Ramsay, 1995; Castellini and Rea, 1992;Cherel
and Groscolas, 1999; Cherel and Le Maho, 1985;
Cherel et al., 1988a, 1988b, 1991; Fond et al., 2013;
Reilly, 1991; Robin et al., 1987, 1988). Phase III
is brief, since the high protein loss leads to death.
During phase III, glucose and total plasma protein
levels are reduced, and uric acid increases while
ketone bodies values remain low. Wild animals that
fast for long periods are efficient at sparing proteins
during long periods of fasting, with only 2%–10%
of total energy coming from proteins versus the
20%–40% in species less adapted to fasting.
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enhancement of synaptic plasticity, neurogenesis, and neuronal
resistance to injury and disease (see sections on fasting and
neurodegeneration below). BDNF signaling in the brain may
also mediate behavioral and metabolic responses to fasting
and exercise, including regulation of appetite, activity levels,
peripheral glucose metabolism, and autonomic control of the
cardiovascular and gastrointestinal systems (Mattson, 2012a,
2012b; Rothman et al., 2012).
Hunger is an adaptive response to food deprivation that
involves sensory, cognitive, and neuroendocrine changes that
motivate and enable food-seeking behaviors. It has been pro-
posed that hunger-related neuronal networks, neuropeptides,
and hormones play pivotal roles in the beneficial effects of en-
ergy restriction on aging and disease susceptibility. As evidence,
when mice in which the hypothalamic ‘‘hunger peptide’’ NPY is
selectively ablated are maintained on a CR diet, the ability of
CR to suppress tumor growth is abolished (Shi et al., 2012).
The latter study further showed that the ability of CR to elevate
circulating adiponectin levels was also compromised in NPY-
deficient mice, suggesting a key role for the central hunger
response in peripheral endocrine adaptations to energy restric-
tion. Adiponectin levels increase dramatically in response to184 Cell Metabolism 19, February 4, 2014 ª2014 Elsevier Inc.fasting; data suggest roles for adiponectin in the beneficial
effects of IF on the cardiovascular system (Wan et al., 2010).
The hunger response may also improve immune function during
aging, as ghrelin-deficient mice exhibit accelerated thymic
involution during aging, and treatment of middle-age mice with
ghrelin increases thymocyte numbers and improves the func-
tional diversity of peripheral T cell subsets (Peng et al., 2012).
In addition to its actions on the hypothalamus and peripheral
endocrine cells, fasting may increase neuronal network activity
in brain regions involved in cognition, resulting in the production
of BDNF, enhanced synaptic plasticity, and improved stress
tolerance (Rothman et al., 2012). Thus, hunger may be a critical
factor involved in widespread central and peripheral adaptive
responses to the challenge of food deprivation for extended
time periods.
Fasting, Aging, and Disease in Rodent Models
Different Fasting Methods and Aging
The major differences between IF and PF in mice are the length
and the frequency of the fast cycles. IF cycles usually last 24 hr
and are 1 to a few days apart, whereas PF cycles last 2 or more
days and are at least 1 week apart, which is necessary for mice
to regain their normal weight. One difference in the molecular
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(A) Neurons in the hippocampus play critical roles in
learning and memory and are vulnerable to
dysfunction and degeneration in Alzheimer’s dis-
ease, stroke, traumatic brain injury, and epilepsy.
The dentate gyrus (yellow) contains neurons that
receive inputs from neurons in the entorhinal cortex
(EC), with the latter brain region serving as a
conduit for sensory information from higher cere-
bral cortical regions involved in responding to
sensory inputs and internally generated cognitive
processes. Increased activity in these neurons
occurs in response to fasting, resulting in the
production of brain-derived neurotrophic factor
(BDNF). BDNF promotes the growth and mainte-
nance of dendrites and synapses and also en-
hances the production and survival of new neurons
from neural stem cells; the newly generated neu-
rons then integrate into the existing neural circuits.
(B) Signaling pathways by which glutamate,
BDNF, insulin, and glucagon-like peptide 1 (GLP-1)
improve neuronal bioenergetics and protect the
neurons against neurodegenerative disease and
traumatic injury. Glutamate activates AMPA and
N-methyl-D-aspartate (NMDA) receptors, resulting
in Ca2+ influx and the activation of Ca2+/calmod-
ulin-sensitive (CaM) kinases which, in turn, activate
the transcription factors cyclic AMP response-
element-binding protein (CREB) and nuclear factor
kB (NF-kB). Genes induced by the latter tran-
scription factor include those encoding BDNF, the
DNA repair enzyme APE1, the master regulator
of mitochondrial biogenesis PGC-1a, and the
antioxidant enzyme manganese superoxide dis-
mutase (MnSOD). BDNF and insulin bind their
respective receptor tyrosine kinases (trkB and the
insulin receptor), resulting in the activation of the
PI3 kinase and Akt kinase. BDNF also stimulates mitogen-activated protein kinases (MAPK). Some of the gene targets of BDNF include PGC-1a, APE1, and
the antiapoptotic protein Bcl-2. Insulin activates the mammalian target of rapamycin (mTOR) pathway to promote protein synthesis and cell growth. Finally,
GLP-1 activates receptors (GLP-1R) coupled to cyclic AMP production, CREB activation, and BDNF production.
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variety of growth factors and metabolic markers, with IF causing
more frequent but less pronounced changes than PF. It will be
important to determine how the frequency of specific changes,
such as the lowering of insulin-like growth factor 1 (IGF-1) and
glucose, affect cellular protection, diseases, and longevity. The
most extensively investigated IF method in animal studies of
aging has been alternate day fasting (food is withdrawn for
24 hr on alternate days, with water provided ad libitum) (Varady
and Hellerstein, 2007). The magnitude of the effects of alternate
day fasting on longevity in rodents depends upon the species
and age at regimen initiation, and can range from a negative
effect to as much as an 30% lifespan extension (Figure 1D)
(Arum et al., 2009; Goodrick et al., 1990). IF every other day
extended the lifespan of rats more than fasting every third or
fourth day (Carlson and Hoelzel, 1946). Fasting for 24 hr twice
weekly throughout adult life resulted in a significant increase in
lifespan of black-hooded rats (Kendrick, 1973). In rats, the com-
bination of alternate day fasting and treadmill exercise resulted in
greater maintenance of muscle mass than did IF or exercise
alone (Sakamoto and Grunewald, 1987). Interestingly, when
rats were maintained for 10 weeks on a PF diet in which they
fasted 3 consecutive days each week, they were less prone to
hypoglycemia during 2 hr of strenuous swimming exercise as a
result of their accumulation of larger intramuscular stores ofglycogen and triglycerides (Favier and Koubi, 1988). Several ma-
jor physiological responses to fasting are similar to those caused
by regular aerobic exercise, including increased insulin sensi-
tivity and cellular stress resistance, reduced resting blood pres-
sure and heart rate, and increased heart rate variability as a result
of increased parasympathetic tone (Figure 2) (Anson et al., 2003;
Mager et al., 2006; Wan et al., 2003). Emerging findings suggest
that exercise and IF retard aging and some age-related diseases
by shared mechanisms involving improved cellular stress adap-
tation (Stranahan and Mattson, 2012). However, in two different
mouse genetic backgrounds, IF did not extend mean lifespan
and even reduced lifespanwhen initiated at 10months (Goodrick
et al., 1990). When initiated at 1.5 months, IF either increased
longevity or had no effect (Figure 1D) (Goodrick et al., 1990).
These results in rodents point not only to conserved effects of
fasting on lifespan but also to the need for a much better under-
standing of the type of fasting that can maximize its longevity ef-
fects and themechanisms responsible for the detrimental effects
that may be counterbalancing antiaging effects. For example,
one possibility is that fasting may be consistently protective in
young and middle-aged laboratory rodents that are either gain-
ing or maintaining a body weight, but may be detrimental in older
animals that, similarly to humans, begin to lose weight at
advanced ages. Notably, whereas bacteria, yeast, and humans
can survive for several weeks or more without nutrients, mostCell Metabolism 19, February 4, 2014 ª2014 Elsevier Inc. 185
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Figure 5. Differential Stress Resistance and
Sensitization in Aging, Disease Prevention,
and Cancer Treatment
(A) In both mice and humans, fasting for 2 or 5 days,
respectively, causes an over 50%decrease in IGF-I,
a 30%ormore decrease in glucose, and a 5–10-fold
increase in the IGF-1 binding protein and inhibitor
IGFBP1 (Cahill, 2006; Lee et al., 2012; Raffaghello
et al., 2008; Thissen et al., 1994a, 1994b). These
and other endocrinological alterations affect the
expression of hundreds of genes in many cell types
and the consequent reduction or halting of growth
and elevation in stress resistance, which may be
dependent in part on FOXO and other stress resis-
tance transcription factors. These periodically
extreme conditions can promote changes, which
are long lasting and delay aging and disease inde-
pendently of calorie restriction, although the cellular
mechanisms responsible for these effects remain poorly understood. In the presence of chemotherapy drugs, fasting can promote the protection of normal, but
not cancer, cells (differential stress resistance [DSR]), since oncogenic pathways play central roles in inhibiting stress resistance, and therefore, cancer cells are
unable to switch to the stress response mode.
(B) The extreme changes caused by fasting, and particularly the very low IGF-1 and glucose levels and high IGFBP1, also generate a tumor prevention envi-
ronment that promotes cancer cell death, since transformed cells have acquired a number of mutations that progressively decrease their ability to adapt to
extreme environments (differential stress sensitization [DSS]) (Guevara-Aguirre et al., 2011; Lee et al., 2010, 2012).
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without food. The age-dependent weight loss may make this
sensitivity to long periods of fasting worse.
Fasting and Cancer
Fasting can have positive effects in cancer prevention and treat-
ment. In mice, alternate day fasting caused a major reduction in
the incidence of lymphomas (Descamps et al., 2005), and fasting
for 1 day per week delayed spontaneous tumorigenesis in
p53-deficient mice (Berrigan et al., 2002). However, the major
decrease in glucose, insulin, and IGF-1 caused by fasting, which
is accompanied by cell death and/or atrophy in a wide range of
tissues and organs including the liver and kidneys, is followed
by a period of abnormally high cellular proliferation in these tis-
sues, driven in part by the replenishment of growth factors during
refeeding. When combined with carcinogens during refeeding,
this increased proliferative activity can actually increase carcino-
genesis and/or precancerous lesions in tissues including liver
and colon (Tessitore et al., 1996). Although these studies under-
line the need for an in-depth understanding of its mechanisms of
action, fasting, when applied correctly even in the presence of
carcinogens, is expected to have cancer-preventive effects, as
indicated by the studies above and by the findings that multiple
cycles of PF can be as effective as toxic chemotherapy in the
treatment of some cancers in mice (Lee et al., 2012).
In the treatment of cancer, fasting has been shown to have
more consistent and positive effects. PF for 2–3 days was shown
to protect mice from a variety of chemotherapy drugs, an effect
called differential stress resistance (DSR) to reflect the inability
of cancer cells to become protected because oncogenes nega-
tively regulate stress resistance, and prevent cancer cells from
becoming protected (Figure 5) (Raffaghello et al., 2008). PF also
causes a major sensitization of various cancer cells to chemo
treatment, since it fosters an extreme environment in combina-
tion with the stress conditions caused by chemotherapy. In
contrast to the protected state entered by normal cells during
fasting, cancer cells are unable to adapt, a phenomenon called
differential stress sensitization (DSS), based on the notion that
most mutations are deleterious and that the many mutations
accumulated in cancer cells promote growth under standard186 Cell Metabolism 19, February 4, 2014 ª2014 Elsevier Inc.conditions but render them much less effective in adapting to
extremeenvironments (Lee et al., 2012). Inmousemodels ofmet-
astatic tumors, combinations of fasting and chemotherapy that
cause DSR and DSS result in 20%–60% cancer-free survival
compared to chemotherapy or fasting alone, which are generally
not sufficient to cause any cancer-free survival (Lee et al., 2012;
Shi et al., 2012). Thus, the idea that cancer could be treated
with weeks of fasting alone, made popular decades ago, may
be only partially true, at least for some type of cancers, but is ex-
pected to be ineffective or only partially effective for many types
of cancers. The efficacy of long-term fasting alone (2 weeks or
longer) in cancer treatment will need to be tested in carefully de-
signed clinical trials in which side effects, including malnourish-
ment, cachexia, and possibly a weakened immune system and
increased susceptibility to certain infections, are carefully moni-
tored. By contrast, animal data from multiple laboratories indi-
cate that the combination of fasting cycles with chemotherapy
is highly and consistently effective in enhancing chemothera-
peutic index and has high translation potential. A number of
ongoing trials should soonbegin to determine the efficacy of fast-
ing in enhancing cancer treatment in the clinic.
Fasting and Neurodegeneration
Compared to ad-libitum-fed controls, rats and mice maintained
on an IF diet exhibit less neuronal dysfunction and degeneration
and fewer clinical symptoms in models of Alzheimer’s disease
(AD), Parkinson’s disease (PD), and Huntington’s disease (HD).
These models include transgenic mice expressing mutant
human genes that cause dominantly inherited AD (amyloid pre-
cursor protein and presenilin-1) and frontotemporal lobe demen-
tia (t) (Halagappa et al., 2007), PD (a-synuclein) (Griffioen et al.,
2012), and HD (huntingtin) (Duan et al., 2003), as well as neuro-
toxin-based models pertinent to AD, PD, and HD (Bruce-Keller
et al., 1999; Duan and Mattson, 1999). Animals on an IF
diet also fare better than ad-libitum-fed controls after acute
injury, including severe epileptic seizures, stroke, and traumatic
brain and spinal cord injuries (Arumugam et al., 2010; Bruce-
Keller et al., 1999; Plunet et al., 2008).
Several interrelated cellular mechanisms contribute to the
beneficial effects of IF on the nervous system, including reduced
Cell Metabolism
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cellular bioenergetics, enhanced neurotrophic factor signaling,
and reduced inflammation (Mattson, 2012a). The latter neuro-
protective mechanisms are supported by studies showing that
IF diets boost levels of antioxidant defenses, neurotrophic fac-
tors (BDNF and FGF2), and protein chaperones (HSP-70 and
GRP-78) and reduce levels of proinflammatory cytokines
(TNF-a, IL-1b, and IL-6) (Figure 4) (Arumugam et al., 2010). IF
may also promote restoration of damaged nerve cell circuits
by stimulating synapse formation and the production of new
neurons from neural stem cells (neurogenesis) (Lee et al.,
2002). Interestingly, while beneficial in models of most neurode-
generative conditions, there is evidence that fasting can hasten
neurodegeneration in some models of inherited amyotrophic
lateral sclerosis, perhaps because the motor neurons affected
in those models are unable to respond adaptively to the moder-
ate stress imposed by fasting (Mattson et al., 2007; Pedersen
and Mattson, 1999).
Fasting and the Metabolic Syndrome
Metabolic syndrome (MS), defined as abdominal adiposity, com-
bined with insulin resistance, elevated triglycerides, and/or hy-
pertension, greatly increases the risk of cardiovascular disease,
diabetes, stroke, and AD. Rats and mice maintained under the
usual ad libitum feeding condition develop anMS-like phenotype
as they age. MS can also be induced in younger animals by
feeding them a diet high in fat and simple sugars (Martin et al.,
2010). IF can prevent and reverse all aspects of the MS in
rodents: abdominal fat, inflammation, and blood pressure are
reduced; insulin sensitivity is increased; and the functional
capacities of the nervous, neuromuscular, and cardiovascular
systems are improved (Castello et al., 2010; Wan et al., 2003).
Hyperglycemia is ameliorated by IF in rodent models of diabetes
(Pedersen et al., 1999), and the heart is protected against
ischemic injury in myocardial infarction models (Ahmet et al.,
2005). A protective effect of fasting against ischemic renal and
liver injury occurs rapidly, with 1–3 days of fasting improving
functional outcome and reducing tissue injury and mortality
(Mitchell et al., 2010). Six days on a diet missing just a single
essential amino acid, such as tryptophan, can also elicit changes
in metabolism and stress resistance, similar to those caused by
fasting, which are dependent on the amino-acid-sensing kinase
Gcn2 (Peng et al., 2012).
Multiple hormonal changes that typify MS in humans are
observed in rodents maintained on high-fat and -sugar diets,
including elevated levels of insulin and leptin and reduced levels
of adiponectin and ghrelin. Elevated leptin levels are typically
reflective of a proinflammatory state, whereas adiponectin and
ghrelin can suppress inflammation and increase insulin sensi-
tivity (Baatar et al., 2011; Yamauchi et al., 2001). Local inflam-
mation in hypothalamic nuclei that control energy intake and
expenditure may contribute to a sustained positive energy bal-
ance in MS (Milanski et al., 2012). Fasting results in a lowering
of insulin and leptin levels and an elevation of adiponectin and
ghrelin levels. By increasing insulin and leptin sensitivity, sup-
pressing inflammation, and stimulating autophagy, fasting
reverses all the major abnormalities of the MS in rodents (Singh
et al., 2009; Wan et al., 2010). Finally, in addition to its many
effects on cells throughout the body and brain, IF may elicit
changes in the gut microbiota that protect against MS (Tremaroliand Ba¨ckhed, 2012). Naturally, the challenge of applying fasting-
based interventions to treat MS in humans is a major one, as
some obese individuals may have difficulties in following IF for
long periods.
Fasting, Aging, and Disease in Humans
Fasting and Factors Implicated in Aging
Clinical and epidemiological data are consistent with an ability of
fasting to retard the aging process and associated diseases.
Major factors implicated in aging whose generation are acceler-
ated by gluttonous lifestyles and slowed by energy restriction in
humans include the following: (1) oxidative damage to proteins,
DNA, and lipids; (2) inflammation; (3) accumulation of dysfunc-
tional proteins and organelles; and (4) elevated glucose, insulin,
and IGF-I, although IGF-1 decreases with aging and its severe
deficiency can be associated with certain pathologies (Bishop
et al., 2010; Fontana and Klein, 2007). Serum markers of oxida-
tive damage and inflammation, as well as clinical symptoms,
are reduced over a period of 2–4 weeks in asthma patients
maintained on an alternate day fasting diet (Johnson et al.,
2007). Similarly, when on a 2 days/week fasting diet, overweight
women at risk for breast cancer exhibited reduced oxidative
stress and inflammation (Harvie et al., 2011), and elderly men
exhibited reductions in body weight and body fat and improved
mood (Teng et al., 2011). Additional effects of fasting in human
cells that can be considered as potentially ‘‘antiaging’’ are inhibi-
tion the mTOR pathway, stimulation of autophagy, and ketogen-
esis (Harvie et al., 2011; Sengupta et al., 2010).
Among the major effects of fasting relevant to aging and dis-
eases are changes in the levels of IGF-1, IGFBP1, glucose,
and insulin. Fasting for 3 or more days causes a 30% or more
decrease in circulating insulin and glucose, as well as rapid
decline in the levels of IGF-1, the major growth factor in mam-
mals, which together with insulin is associated with accelerated
aging and cancer (Fontana et al., 2010). In humans, 5 days of
fasting causes an over 50% decrease in IGF-1 and a 5-fold or
higher increase in one of the principal IGF-1-inhibiting proteins,
IGFBP1 (Thissen et al., 1994a). This effect of fasting on IGF-1
is mostly due to protein restriction, and particularly to the restric-
tion of essential amino acids, but is also supported by calorie
restriction since the decrease in insulin levels during fasting pro-
motes reduction in IGF-1 (Thissen et al., 1994a). Notably, in
humans, chronic calorie restriction does not lead to a decrease
in IGF-1 unless combined with protein restriction (Fontana
et al., 2008).
IF can be achieved in with aminimal decrease in overall calorie
intake if the refeeding period in which subjects overeat is consid-
ered. Thus, fasting cycles provide a muchmore feasible strategy
to achieve the beneficial effects of CR, and possibly stronger
effects, without the burden of chronic underfeeding and some
of the potentially adverse effects associated with weight loss
or very low BMIs. In fact, subjects who are moderately over-
weight (BMI of 25–30) in later life can have reduced overall mor-
tality risk compared to subjects of normal weight (Flegal et al.,
2013). Although these results may be affected by the presence
of many existing or developing pathologies in the low weight
control group, they underline the necessity to differentiate be-
tween young and middle age individuals and elderly individuals
when using CR or fasting to reduce weight or delay aging.Cell Metabolism 19, February 4, 2014 ª2014 Elsevier Inc. 187
Cell Metabolism
ReviewAlthough extreme dietary interventions during old age may
continue to protect from age-related diseases, they could have
detrimental effects on the immune system and the ability to
respond to certain infectious diseases, wounds, and other chal-
lenges (Kristan, 2008; Reed et al., 1996). However, IF or PF
designed to avoid weight loss and maximize nourishment have
the potential to have beneficial effects even on infectious dis-
eases, wounds, and other insults even in the very old. Studies
to test the effect of IF or PF regimens on markers of aging,
cancer, cognition and obesity are in progress (V.D.L. and
M.P.M., unpublished data).
Fasting and Cancer
Fasting has the potential for applications in both cancer preven-
tion and treatment. Although no human data are available on the
effect of IF or PF in cancer prevention, their effect on IGF-1,
insulin, glucose/IGFBP1, and ketone body levels could generate
a protective environment that reduces DNA damage and carci-
nogenesis while at the same time creating hostile conditions
for tumor and precancerous cells (Figure 5). In fact, elevated
circulating IGF-1 is associated with increased risk of developing
certain malignancies (Chan et al., 2000; Giovannucci et al.,
2000), and individuals with severe IGF-1 deficiency caused by
growth hormone receptor deficiency rarely develop cancer
(Guevara-Aguirre et al., 2011; Steuerman et al., 2011). Further-
more, the serum from these IGF-1-deficient subjects protected
human epithelial cells from oxidative-stress-induced DNA dam-
age. Furthermore, once their DNA became damaged, cells were
more likely to undergo programmed cell death (Guevara-Aguirre
et al., 2011). Thus, fasting may protect from cancer not only by
reducing cellular and DNA damage but also by enhancing the
death of precancerous cells.
In a preliminary study of 10 subjects with a variety of malig-
nancies, the combination of chemotherapy with fasting resulted
in a decrease in a range of self-reported common side effects
caused by chemotherapy compared to the same subjects
receiving chemotherapy while on a standard diet (Safdie et al.,
2009). The effect of fasting on chemotherapy toxicity and cancer
progression is now being tested in clinical trials in both Europe
and the US (0S-08-9 and 0S-10-3).
Fasting and Neurodegeneration
Our current understanding of the impact of IF on the nervous
system and cognitive functions is largely inferred from animal
studies (see above). Interventional studies to determine the
impact of fasting on brain function and neurodegenerative dis-
ease processes are lacking. After 3–4 months, CR improved
cognitive function (verbal memory) in overweight women
(Kretsch et al., 1997) and in elderly subjects (Witte et al., 2009).
Similarly, when subjects with mild cognitive impairment were
maintained for 1 month on a low glycemic diet, they exhibited
improved delayed visual memory, cerebrospinal fluid bio-
markers of Abmetabolism and brain bioenergetics (Bayer-Carter
et al., 2011). Studies in which cognitive function, regional brain
volumes, neural network activity, and biochemical analyses of
cerebrospinal fluid are measured in human subjects before and
during an extended period of IF should clarify the impact of IF
on human brain structure and function.
Fasting, Inflammation, and Hypertension
In humans, one of the best demonstrations of the beneficial ef-
fects of long-term fasting lasting 1 to 3 weeks is in the treatment188 Cell Metabolism 19, February 4, 2014 ª2014 Elsevier Inc.of rheumatoid arthritis (RA). In agreement with the results in
rodents, there is little doubt that during the period of fasting
both inflammation and pain are reduced in RA patients (Mu¨ller
et al., 2001). However, after the normal diet is resumed, inflam-
mation returns unless the fasting period is followed by a vege-
tarian diet (Kjeldsen-Kragh et al., 1991), a combination therapy
that has beneficial effects lasting for 2 years or longer (Kjeld-
sen-Kragh et al., 1994). The validity of this approach is supported
by four differently controlled studies, including two randomized
trials (Mu¨ller et al., 2001). Therefore, fasting combined with a
vegetarian diet and possibly with other modified diets provides
beneficial effects in the treatment of RA. Alternate day IF also
resulted in significant reductions in serum TNF-a and ceramides
in asthma patients during a 2 month period (Johnson et al.,
2007). The latter study further showed that markers of oxidative
stress often associated with inflammation (protein and lipid
oxidation) are significantly reduced in response to IF. Thus, for
many patients able and willing to endure long-term fasting and
to permanently modify their diet, fasting cycles would have the
potential not only to augment but also to replace existingmedical
treatments.
Water-only and other forms of long-term fasting have also
been documented to have potent effects on hypertension. An
average of 13 days of water-only fasting resulted in the achieve-
ment of a systolic blood pressure (BP) below 120 in 82% of
subjects with borderline hypertension with a mean 20 mm Hg
reduction in BP (Goldhamer et al., 2002). BP remained signifi-
cantly lower compared to baseline even after subjects resumed
the normal diet for an average of 6 days (Goldhamer et al., 2002).
A small pilot study of patients with hypertension (140 mm and
above systolic BP) also showed that 10–11 days of fasting
caused a 37–60 mm decrease in systolic BP (Goldhamer et al.,
2001). These preliminary studies are promising but underscore
the need for larger controlled and randomized clinical studies
that focus on PF strategies that are feasible for a larger portion
of the population.
For both hypertension and RA, it will be important to develop
PF-mimicking diets that are as effective as the fasting regimens
described above but that are also tolerable by the great majority
of patients.
Fasting and the MS
PF can reverse multiple features of the MS in humans: it
enhances insulin sensitivity, stimulates lipolysis, and reduces
blood pressure. Body fat and blood pressure were reduced
and glucose metabolism improved in obese subjects in
response to an alternate day modified fast (Klempel et al.,
2013; Varady et al., 2009). Overweight subjects maintained for
6 months on a twice weekly IF diet in which they consumed
only 500–600 calories on the fasting days, lost abdominal fat,
displayed improved insulin sensitivity, and reduced blood pres-
sure (Harvie et al., 2011). Three weeks of alternate day fasting re-
sulted in reductions in body fat and insulin levels in normal weight
men and women (Heilbronn et al., 2005), and Ramadan fasting
(two meals/day separated by approximately 12 hr) in subjects
with MS resulted in decreased daily energy intake, decreased
plasma glucose levels, and increased insulin sensitivity (Shariat-
panahi et al., 2008). Subjects undergoing coronary angiography
who reported that they fasted regularly exhibited a lower preva-
lence of diabetes compared to nonfasters (Horne et al., 2012).
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(BMI of 25) after 15 days of alternate day fasting: their whole-
body glucose uptake rates increased significantly and levels of
plasma ketone bodies and adiponectin were elevated, all of
which occurred without a significant decrease in body weight
(Halberg et al., 2005). The latter findings are similar to data
from animal studies showing that IF can improve glucose meta-
bolism even with little or no weight change (Anson et al., 2003). It
will be important to determine if longer fasting periods, which
promote a robust switch to a fat breakdown and ketone-body-
based metabolism, can cause longer lasting and more potent
effects.
Conclusions and Recommendations
Based on the existing evidence from animal and human studies
described, we conclude that there is great potential for lifestyles
that incorporate IF or PF during adult life to promote optimal
health and reduce the risk of many chronic diseases, particularly
for those who are overweight and sedentary. Animal studies
have documented robust and replicable effects of fasting on
health indicators including greater insulin sensitivity and reduced
levels of blood pressure, body fat, IGF-I, insulin, glucose, athero-
genic lipids, and inflammation. Fasting regimens can ameliorate
disease processes and improve functional outcome in animal
models of disorders that include cancer, myocardial infarction,
diabetes, stroke, AD, and PD. One general mechanism of action
of fasting is that it triggers adaptive cellular stress responses,
which result in an enhanced ability to cope with more severe
stress and counteract disease processes. In addition, by pro-
tecting cells from DNA damage, suppressing cell growth, and
enhancing apoptosis of damaged cells, fasting could retard
and/or prevent the formation and growth of cancers.
However, studies of fasting regimens have not been per-
formed in children, the very old, and underweight individuals,
and it is possible that IF and PF would be harmful to these pop-
ulations. Fasting periods lasting longer than 24 hr, and particu-
larly those lasting 3 or more days, should be done under the
supervision of a physician and preferably in a clinic. IF- and
PF-based approaches toward combating the current epidemics
of overweight, diabetes, and related diseases should be pursued
in human research studies and medical treatment plans. Several
variations of potential ‘‘fasting prescriptions’’ that have been
adopted for overweight subjects revolve around the common
theme of abstaining from food and caloric beverages for at least
12–24 hr on 1 or more days each week or month, depending on
the length, combined with regular exercise. For those who are
overweight, physicians could ask their patients to choose a fast-
ing-based intervention that they believe they could comply with
based upon their daily and weekly schedules. Examples include
the ‘‘5:2’’ IF diet (Harvie et al., 2011), the alternate day modified
fasting diet (Johnson et al., 2007; Varady et al., 2009), a 4–5 day
fast (Lee et al., 2012; Safdie et al., 2009), or low-calorie-but high-
nourishment fasting-mimicking diets once every 1–3 months fol-
lowed by the skipping of one major meal every day if needed
(V.D.L., unpublished data). One of the concerns with unbalanced
alternating diets, such as those in which low calorie intake is only
observed for 2 days aweek, are the potential effects on circadian
rhythm and the endocrine and gastrointestinal systems, which
are known to be influenced by eating habits. During the first 4–6 weeks of implementation of the fasting regimen, a physician
or registered dietitian should be in regular contact with the pa-
tient to monitor their progress and to provide advice and super-
vision.
Fasting regimens could also be tailored for specific diseases
as stand-alone or adjunct therapies. Results of initial trials of IF
(fasting 2 days per week or every other day) in human subjects
suggest that there is a critical transition period of 3–6 weeks dur-
ing which time the brain and body adapt to the new eating
pattern and mood is enhanced (Harvie et al., 2011; Johnson
et al., 2007). Though speculative, it is likely that during the latter
transition period brain neurochemistry changes so that the
‘‘addiction’’ to regular consumption of food throughout the day
is overcome. Notably, the various fasting approaches are likely
to have limited efficacy, particularly on aging and conditions
other than obesity, unless combinedwith high-nourishment diets
such as the moderate calorie intake and mostly plant-based
Mediterranean or Okinawa low-protein diets (0.8 g protein/kg
of body weight), consistently associated with health and
longevity.
In the future, it will be important to combine epidemiological
data, studies of long-lived populations and their diets, and re-
sults from model organisms connecting specific dietary compo-
nents to proaging and prodisease factors, with data from clinical
studies, to design large clinical studies that integrate fasting with
diets recognized as protective and enjoyable. A better under-
standing of the molecular mechanisms by which fasting affects
various cell types and organ systems should also lead to the
development of novel, FDA-approved prophylactic and preven-
tive and therapeutic interventions for a wide range of disorders.
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